Abstract
The following review discusses the successful application of X-ray, NMR, and molecular modeling in the design of potent and selective inhibitors of matrix metalloproteinases (MMPs) and TNFα-converting enzyme (TACE) from Wyeth. The importance of protein and ligand mobility as it impacts structure-based design is also discussed. The MMPs are an active target for a variety of diseases, including cancer and arthritis.
Original language | English (US) |
---|---|
Pages (from-to) | 1311-1327 |
Number of pages | 17 |
Journal | Current Topics in Medicinal Chemistry |
Volume | 4 |
Issue number | 12 |
DOIs | |
State | Published - 2004 |
Keywords
- Inhibitor
- MMP
- Matrix metalloprotease
- Matrix metalloproteinase
- Molecular modeling
- NMR
- Structure-based drug design
- X-ray
ASJC Scopus subject areas
- Drug Discovery